12 Aug 2026 Biovia translates Roadmaps into four COOCK+ project proposals and is inviting members to join Multiple categories
04 Aug 2026 Biovia launches six strategic Roadmaps to shape the future of health innovation Multiple categories
01 Jun 2026 Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia Multiple categories
25 May 2026 From Sample Collections to Critical Infrastructure: Experts are Calling for Changes to Belgium’s Biobanks Multiple categories
12 May 2026 Flen Health Pharma NV Receives Positive FDA Feedback on VES Gel for Diabetic Foot Ulcers Multiple categories
30 Apr 2026 Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554 Multiple categories
02 Apr 2026 SwiftPharma Expands R&D Footprint to Leuven in Strategic Co-Location with Benno Therapeutics Multiple categories
19 Feb 2026 SwiftPharma announces partnership with Medicines Patent Pool and Population Council on Project ELYRA to expand pathways for Griffithsin-based STI prevention Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
